Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment
S. Biesterfeld et al., Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment, VIRCHOWS AR, 438(5), 2001, pp. 478-484
Citations number
50
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
Recently, it was stated that the proliferative activity (P) of a cell popul
ation could be indirectly calculated by multiplying the MIB-1 immunopositiv
ity and silver-stainable nucleolar organizer region (AgNOR) features extrac
ted exclusively in MIB-1 positive (pos.) nuclei: P=MIB- 1xAgNOR(MIB-1pos).
To study the prognostic significance of this hypothesis, MIB-1 immunohistoc
hemistry and AgNOR staining were applied on a series of 89 cases of breast
cancer with an 8-year follow-up period. The mean MIB-1 immunopositivity (MI
B-1(mean)) was evaluated immunohistometrically on paraffin sections using a
TV image analysis system CM-2 (Hund, Wetzlar, Germany). Later, a combined
MIB-1/AgNOR staining was applied and evaluated using a TV image analysis sy
stem AMBA (IBSB, Berlin, Germany). The AgNOR features of 150 randomly chose
n tumor nuclei were investigated, irrespective of their MIB-1 status (AgNOR
count, AgNOR area). Later, a second measurement was performed on 100 MIB-1
positive tumor nuclei exclusively (AgNOR count(MIB)-(1pos.5) AgNOR area(MI
B-1pos.)). AgNOR count and AgNOR count(MIB-1pos.), showed a different data
distribution [2.7 +/-0.7 (mean +/- SD) vs 3.9 +/-1.1; r=0.315, P=0.014]. Si
milar results were obtained for AgNOR area and AgNOR area(MIB-1pos.) (5.1 /-2.1 mum(2) vs 7.5 +/-2.4 mum(2); r-0.501, P<0.001). Kaplan-Meier survival
curves revealed significant differences for MLB-1(mean), (P=0.0018) and Ag
NOR area(MIB-1pos) (P=0.0340). In Cox models, both parameters provided Inde
pendent prognostic information. Using their combination, the P, three group
s of patients with statistically different survival could be separated (P=0
.0014). Thus, the combination of MIB-1-immunopositivity and AgNOR measureme
nts in MIB-1 positive nuclei appears to be more useful in breast cancer pro
gnosis than the exclusive application of one of the two methods. By this co
mbined application, probably effects of tumor biology are represented more
precisely.